Boosting BNT162b2 vaccine efficacy in CLL

Blood. 2022 Feb 3;139(5):639-640. doi: 10.1182/blood.2021014903.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Vaccine Efficacy

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine